Tag
USFDA
2 articles
Dr. Reddy's USFDA Inspection Concludes with Four Observations
USFDA completed a GMP inspection at Dr. Reddy's Bachupally formulations plant from August 6-14, 2026.
The inspection resulted in a Form 483 issuance containing four observations for the facility.
Dr.
Dr. Reddy's UK API Facility USFDA Inspection Closed VAI
USFDA closed its GMP inspection at Dr. Reddy's UK API facility with a Voluntary Action Indicated (VAI) classification.
The inspection, conducted at the Mirfield, West Yorkshire facility, is officially